/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
MyndYou Teams up with Mizuho Information & Research Institute to Detect Changes in Cognitive Function in Senior Adults in Japan
The Digital Health company MyndYou recently secured its Seed round of
financing from Howard L. Morgan, Amplifyher Ventures, Female Founders
Fund, Impact 1st and more.
NEW YORK–(BUSINESS WIRE)–#AI–MyndYou and Mizuho Information & Research Institute (MHIR) have entered
into a partnership agreement to conduct a joint PoC in the Japanese
Market to improve quality of life and prolong independence of senior
adults. The companies aim to commercialize the service by the end of
FY2019.
MHIR will leverage MyndYou’s Artificial Intelligence (AI) platform,
which passively detects changes in cognitive function of individuals
through voice. The platform then delivers actionable insights to care
providers. MyndYou’s full solution allows for detection of changes in
cognitive function through passive tracking of voice and additional
parameters such as walking, driving and daily activities.
This partnership is announced on the heels of MyndYou’s Seed financing
round, led by Howard L. Morgan, with participation by Amplifyher
Ventures, Female Founders Fund and additional investors. MyndYou’s Seed
round brings its financing to-date to $2.1 Million.
The company entered the US market last year and is expanding services to
Physician Practices, ACOs, Home Health Companies and Rehabilitation
Companies.
“As a growing NY-based company with proprietary technology developed in
Tel Aviv, we have partnered with MHIR to further the global potential
for MyndYou,” says Ruth Polikaine, CEO of MyndYou. “Now, the senior
adult population in Japan will have access to a technology that can not
only reduce readmission rates, but also prolong their independence,
while providing them with personalized, data-driven remote care.”
“The number of dementia patients in Japan has reached 4.62 million and
is expected to increase even further to seven million, which equals to
one in five seniors over 65, in 2025. The disease has become an
important problem not only for the medical field but also for the entire
Japanese society※1. As in many cases, individuals with
dementia receive the diagnosis only after the symptoms have progressed.
Making a diagnosis and providing adequate care in the early stage is
necessary.” says Hitoshi Morio, Joint General Manager, Innovation &
Strategy Division, Mizuho Information & Research.
“However, the
number of opportunities to grasp changes in cognitive function in the
early stage has declined with the increase of single- person households
and the decrease of chances to interact with others. We see a big
opportunity to change that through the partnership with MyndYou.”
※1 ”White Paper on Aging Society/ 2016” by the
Cabinet of Japan
About MHIR
With IT as its core
technology, Mizuho Information & Research Institute, Inc. (MHIR) is a
professional organization with approximately 4,700 employees that
provides assistance to corporations in increasing their corporate value
through consulting, system integration and outsourcing services. Our
consulting services provide high-quality solutions to customers, with
experts in four distinct fields looking one step into the future:
socioeconomics, telecommunications, environmental energy and science.
MHIR
is one of core group companies of Mizuho Financial Group.
About MyndYou
The MyndYou artificial
intelligence (AI) platform was designed to revolutionize
cognitive-driven care. Through groundbreaking analytics of speech and
day-to-day activity patterns of older adults collected through remote
care sessions and a seamless monitoring app, MyndYou detects subtle
changes in cognitive functioning that activates care adjustments and
timely interventions. With passive and continuous monitoring, AI-driven
actionable insights, and seamless integration into today’s care methods,
MyndYou empowers clinicians to deliver personalized care that
revolutionizes patient engagement, reduces healthcare costs, and
improves quality of life.
Contacts
For inquiries, please contact:
Ruth Poliakine
CEO
MyndYou
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE2 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis1 day ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis1 day ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical